Core a
The specific aims of the resource for Clinical Studies of AKI (Core A) are to:
(1): Provide access to clinical data of patients at risk for or with AKI and consultation for their use.
(1a): Provide consultation and access to curated clinical data from prior clinical studies hosted by Core A.
(1b): Provide access to new harmonized real-world data from the EHR to novel clinical research.
(1a): Provide consultation and access to curated clinical data from prior clinical studies hosted by Core A.
(1b): Provide access to new harmonized real-world data from the EHR to novel clinical research.
(2): Provide access to biospecimens of patients at risk for or with AKI and consultation for their use.
(2a): Provide consultation and access to biospecimens from prior studies hosted by Core A.
(2b): Provide a novel platform to link biospecimens of patients at risk for or with AKI with EHR data.
(2a): Provide consultation and access to biospecimens from prior studies hosted by Core A.
(2b): Provide a novel platform to link biospecimens of patients at risk for or with AKI with EHR data.
Clinical Core plans to use existing data repositories and biospecimens as well as new data from EHR and Biospecimens linked to EHR data.
Biomedical Resource Clinical Care supports:
- Bioinformatics Resources: Jake Chen, PhD, Jin Chen, PhD & Jejo Koola, MD, MS
- Biostatistical Resources: Ashutosh Tamhane, PhD & Gary Cutter, PhD
- Clinical Trial Resources: Lama Ghazi, MD, PhD & Joachim Ix, MD
- Biorepository Resources: Frida Rosenblum, MD & Sucheta Vaingankar, PhD